CAPR
Capricor Therapeutics Inc
8.60$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | |
| 4.5% | 82.2% | 226.2% | 314.9% | 522.1% | 130.8% | – | – | – | – | – | – | – | |
| 100.0% | 17.8% | -126.2% | -214.9% | -422.1% | -30.8% | – | – | – | – | – | – | – | |
| 162.1% | 82.2% | 226.2% | 314.9% | 522.1% | 130.8% | – | – | – | – | – | – | – | |
| 47.0% | 28.4% | 83.0% | 77.0% | 153.1% | 38.4% | – | – | – | – | – | – | – | |
| 211.0% | 28.4% | 83.0% | 77.0% | 153.1% | 38.4% | – | – | – | – | – | – | – | |
| -111.0% | -10.6% | -209.2% | -291.9% | -575.2% | -69.2% | – | – | – | – | – | – | – | |
| – | 3,436.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -103.3% | -6.3% | -199.6% | -277.0% | -555.2% | -63.9% | – | – | – | – | – | – | – | |
| -4.5% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| -103.3% | -6.3% | -199.6% | -277.0% | -555.2% | -63.9% | – | – | – | – | – | – | – | |
| -98.8% | -3.8% | -192.8% | -268.0% | -539.2% | -60.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.